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Abstract
A central tenet in support of research reproducibility is the ability to uniquely 
identify research resources, i.e., reagents, tools, and materials that are used to 
perform experiments. However, current reporting practices for research 
resources are insufficient to allow humans and algorithms to identify the exact 
resources that are reported or answer basic questions such as “What other 
studies used resource X?” To address this issue, the Resource Identification 
Initiative was launched as a pilot project to improve the reporting standards for 
research resources in the methods sections of papers and thereby improve 
identifiability and reproducibility. The pilot engaged over 25 biomedical journal 
editors from most major publishers, as well as scientists and funding officials. 
Authors were asked to include Research Resource Identifiers (RRIDs) in their 
manuscripts prior to publication for three resource types: antibodies, model 
organisms, and tools (including software and databases). RRIDs represent 
accession numbers assigned by an authoritative database, e.g., the model 
organism databases, for each type of resource. To make it easier for authors to 
obtain RRIDs, resources were aggregated from the appropriate databases and 
their RRIDs made available in a central web portal ( 
www.scicrunch.org/resources). RRIDs meet three key criteria: they are 
machine readable, free to generate and access, and are consistent across 
publishers and journals. The pilot was launched in February of 2014 and over 
300 papers have appeared that report RRIDs. The number of journals 
participating has expanded from the original 25 to more than 40. Here, we 
present an overview of the pilot project and its outcomes to date. We show that 
authors are generally accurate in performing the task of identifying resources
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and supportive of the goals of the project. We also show that identifiability of 
the resources pre- and post-pilot showed a dramatic improvement for all three 
resource types, suggesting that the project has had a significant impact on 
reproducibility relating to research resources.
Corresponding author: Anita Bandrowski (abandrowski@ncmir.ucsd.edu)
How to cite this article: Bandrowski A, Brush M, Grethe JS etal. The Resource Identification Initiative: A cultural shift in publishing [v1; 
ref status: indexed, http://f1000r.es/5fj] F1000Research 2015, 4:134 (doi: 10.12688/f1000research.6555.1)
Copyright: © 2015 Bandrowski A et al. This is an open access article distributed under the terms of the Creative Commons Attribution Licence, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the 
article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
Grant information: This work was supported by: an NIF grant to Martone PI (HHSN271200577531C/PHS HHS/United States); a NIDDK grant to 
Martone PI (1U24DK097771-01); and a grant from Monarch to Haendel PI (5R24OD011883).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors declared no competing interests.
First published: 29 May 2015, 4:134 (doi: 10.12688/f1000research.6555.1)
First indexed: 18 Jun 2015, 4:134 (doi: 10.12688/f1000research.6555.1)
Page 2 of 16
F1000Research 2015, 4:134 Last updated: 18 JUN 2015
Introduction
Research resources, defined here as the reagents, materials, and tools 
used to produce the findings of a study, are the cornerstone of bio­
medical research. However, as has long been bemoaned by database 
curators and documented recently by Vasilevsky and colleagues, these 
resources are not very well identified in the scientific literature11. 
Vasilevsky and colleagues found that researchers did not include suf­
ficient detail for most key research resources to allow someone to 
identify conclusively an antibody, a genetically modified animal, or 
cell lines, for example. In most cases, authors would provide insuffi­
cient metadata about the resource to conclusively identify a particular 
resource, e.g., a non-unique set of attributes with no catalog or stock 
number to specifically identify the resource used. It should be noted 
that the authors were, generally speaking, following the guidelines 
offered by the journals. Such guidelines traditionally state that one 
should include the company name and city in which it was located. 
Further, even when uniquely identifying information was provided 
(e.g., a catalog number for a particular antibody), the vendor may 
have gone out of business or the particular product may no longer 
be available. Given that in these cases a human cannot find which 
resources were used, an automated agent, such as a search engine or 
text mining tools will also not be able to identify the resources.
Because the current practices for reporting research resources within 
the literature are inadequate, non-standardized and not optimized for 
machine-based access, it is currently exceedingly difficult to answer 
very basic questions about published studies such as “What stud­
ies used the transgenic mouse I am interested in?” These types of 
questions are of interest to the biomedical community, which relies 
on the published literature to identify appropriate reagents, trou­
bleshoot experiments, and aggregate information about a particular 
organism or reagent to form hypotheses about mechanism and func­
tion. Such information is also critical to funders who paid a research 
group to generate a particular tool or reagent and the resource pro­
viders, both commercial and academic, who would like to be able to 
track the use of these resources in the literature. Beyond this basic 
utility, identification of the particular research resource used is an 
important component of scientific reproducibility or lack thereof.
The Resource Identification Initiative (RII) is laying the founda­
tion of a system for reporting research resources in the biomedi­
cal literature that will support unique identification of research 
resources used within a particular study. The initiative is jointly led 
by the Neuroscience Information Framework (NIF; http://neuinfo. 
org) and the Oregon Health Science University (OHSU) Library, 
data integration efforts occurring as part of the Monarch Initiative, 
http://www.monarchinitiative.org), and with numerous community 
members through FORCE11, the Future of Research Communi­
cations and e-Scholarship, a grassroots organization dedicated to 
transforming scholarly communication through technology. Since 
2006, NIF has worked to identify research resources of relevance to 
neuroscience. The OHSU group has long-standing ties to the model 
organism community, which maintains databases populated by curat­
ing the literature and contacting authors to add links between model 
organisms, reagents, and other data. In a 2011 workshop (see https:// 
www.force11 .org/node/4145) held under the auspices of the Linking 
Animal Models to Human Diseases (LAMHDI) consortium, various 
stakeholders from this community drafted recommendations for bet­
ter reporting standards for animal models, genes, and key reagents.
The RII initiative was launched as a result of two planning meet­
ings building off of the recommendations of the LAMHDI work­
shop. The first was held in 2012 at the Society for Neuroscience 
meeting with over 40 participants comprising editors, publishers 
and funders (sponsored by INCF; http://incf.org). This meeting out­
lined the problem of incomplete identification of research resources 
within papers, and the need for a computational solution for iden­
tifying and tracking them in the literature. Recognizing that any 
solution needed to work for both humans and machines, three broad 
requirements were identified: 1) the standard should be machine- 
processable - that is, designed for search algorithms, in addition to 
human understanding; 2) the information should be available out­
side the paywall, so that search algorithms and humans have free 
access to the information across the biomedical literature; and 3) the 
standard should be uniform across publishers, to make uptake and 
usage easier for both human and machine.
A follow-up workshop at the NIH (https://www.force11.org/ 
node/4857) was held in June of 2013 to gain agreement from this 
stakeholder group for the design of a pilot that would explore solu­
tions for this problem. A working group, the Resource Identifica­
tion Initiative, was established through FORCE11, comprised of 
publishers, journal editors, antibody manufacturers and distributors, 
biocurators, software tool developers, and foundations. Based upon 
agreements garnered at the June 2013 meeting, the RII designed a 
pilot project to test implementation of a system for authors submit­
ting manuscripts to identify research resources through the use of a 
unique identifier, termed a Research Resource Identifier or RRID.
Pilot project overview
The pilot project has focused on a limited number of resources - 
antibodies, software tools/databases, and model organisms. These 
three resource types were chosen because they are a major source of 
variation across experiments and are used broadly across research 
communities. For the purposes of this pilot, a critical aspect was 
that a relatively complete and authoritative central registry existed 
that could issue an accession number, as Genbank does for gene 
sequences. To gain broad agreement amongst publishers and edi­
tors who were concerned about the potential burden on authors and 
staff, it was agreed that participation in the pilot project would be 
voluntary for authors with participation not representing a condition 
of acceptance for publication. The pilot project was also designed 
to have minimal requirements for publishers such that modification 
of manuscript submission systems was not required.
The pilot project was originally designed to run for 6 months, 
with each of the participating journals agreeing to participate for 
at least 3 months. The goal was to ensure a large enough sample 
to understand author behavior: could they and would they do the 
task, to test the sufficiency of the infrastructure, and to obtain a 
sufficiently large dataset to explore and demonstrate the utility of 
RRIDs. Over the minimum 3-month window, each partner journal 
would request that authors supply RRIDs in a standard format as a 
citation to indicate the use of any of these three types of research 
resources. To be as unambiguous as possible, authors were to 
include the RRIDs in the text of the materials and methods, but 
not in the introduction or discussion sections. The RRID syntax 
comprises an accession number assigned by the authoritative data­
base with the prefix “RRID:” prepended (e.g., RRID:AB_2298772
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for an antibody). We also requested that closed-source journals 
include RRIDs in the keyword field as this field is available for 
indexing in PubMed outside of paywalls. The journals were given 
flexibility for when and how they wanted to ask authors for these 
identifiers, namely, at time of submission, during review, or after 
acceptance. They were not required to modify their instructions 
to authors or their submission systems. The RII team would be 
responsible for preparing appropriate materials for requesting 
RRIDs and for establishing a central portal where these identifiers 
could be obtained. The RII team also agreed to establish a help 
desk to assist the authors if they encountered any difficulties.
The pilot project was designed to address four key questions. A set 
of evaluation criteria was designed for each question:
1. Compliance: Would authors be willing to add resource 
identifiers to their publications and register new resources 
in the system? Compliance was evaluated by examining the 
number of submissions to the participating journals, the rate 
of author compliance in providing RRIDs, the number of new 
resources registered, and direct feedback from authors.
2. Accuracy: Could authors add these identifiers accurately or 
would additional editorial or staff oversight be necessary? 
Accuracy was measured by a quantitative analysis of RRID 
accuracy by RII curators.
3. Identifiability: Would the use of RRIDs improve our ability 
to identify resources in the literature? Identifiability was 
measured by assessing the number of catalog numbers pre- 
and post-pilot in the journals that participated.
4. Utility: Will RRID’s be useful to the scientific community? Can 
the RRID’s as constructed be used to identify all studies that use 
a particular research resource? To encourage the development 
of applications, the data set is being made freely available so 
that third parties can develop tools to work with RRIDs.
The pilot began in February 2014, with over 25 journals participat­
ing. Journals that sent a letter to authors at some stage of the review 
process included: Journal of Neuroscience, Brain and Behavior, 
Journal of Comparative Neurology, Brain Research, Experimental 
Neurology, F1000Research, PeerJ, Journal of Neuroscience Meth­
ods, Neurobiology of Disease, and the Frontiers group of journals. 
One journal, Neuroinformatics, chose to add the RRIDs to all manu­
scripts before asking authors to do this. Journals in the Elsevier and 
BMC groups were participants based upon updates to their instruc­
tions to authors. Because of the success of the project, it was subse­
quently extended and is still active as of this writing. The number of 
journals participating has expanded, and now includes PLoS Biology 
and PLoS Genetics as well as multiple immunology journals in the 
Elsevier family. A list of the participating journals is available on 
the Force11 website (https://www.force11.org/RII/SignUp).
Workflow
One of the prime requirements of the pilot project was to make it 
as easy as possible for authors to obtain the appropriate identifiers 
and insert them correctly into their manuscripts. As noted above, 
the three research resources were chosen because each was covered 
by an authoritative database (Table 1) that assigned unique IDs and 
a standard set of metadata to each. However, as can be seen by the 
length of the list in Table 1, authors could potentially be required to 
visit several databases to obtain the appropriate identifiers.
Table 1. Source databases and registries included in the RII portal. Each database has a weekly 
or monthly scheduled frequency of update and all new data is released weekly. If available, data 
from both model organism authorities is served as well as the list of strains available via particular 
stock centers. In most cases the stock centers maintain a link between the genotype and the stock 
center animal identifier. Scheduling and total data count information can be accessed via DISCO 
(http://disco.neuinfo.org/webportal/dataPipelineViewStatus.do?id=nlx_154697-1).
Resource name Resource content Database Identifier
ZIRC, Zebrafish Resource Center Zebrafish Stocks RRID:nif-0000-00242
ZFIN, Zebrafish Information Network Zebrafish Nomenclature RRID:nif-0000-21427
RGD, Rat Genome Database Rat RRID:nif-0000-00134
CGC, Caenorhabditis Genetics Center Worm Stocks RRID:nif-0000-00240
WormBase Worm Nomenclature RRID:nif-0000-00053
IMSR, International Mouse Strain Resource 
Center Mouse Stocks RRID:nif-0000-09876
BDSC, Bloomington Drosophila Stock Center Fly Stocks RRID:nif-0000-00241
MGI, Mouse Genome Informatics Mouse Nomenclature RRID:nif-0000-00096
BCBC, Beta Cell Biology Consortium Mouse stocks RRID:nlx_144143
antibodyregistry.org, Antibody Registry Antibodies RRID:nif-0000-07730
SciCrunch Registry Software Tools and Databases RRID:nlx_144509
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To simplify this process, we utilized the data aggregation services of 
the NIF, provided through a platform known as SciCrunch, to estab­
lish a Resource Identification Portal (http://scicrunch.org/resources; 
Figure 1). The portal provided a unified query across these different 
databases and displayed the results in a common format. The por­
tal allows search on various facets such as resource name, catalog 
number, etc. There is a ‘cite this’ link that provides the citation as it 
should be reported in the paper. The citation generally includes not 
just the RRID, but a set of appropriate metadata that would identify 
the vendor and catalog number as well, for example: A polyclo­
nal antibody against tyrosine hydroxylase (TH) (Chemicon, Cat. 
AB1542, RRID:AB_90755).
SciCrunch was built based on the extensible Neuroscience Infor­
mation Framework platform described previously (12,13, RRID: 
nif-0000-25673), and the portal infrastructure for RII was devel­
oped under an award from NIDDK to create a dkNET portal (RRID: 
nlx_153866), while the customization of the portal was done by 
Monarch staff. The data is aggregated from the SciCrunch tool 
registry, the antibody registry, as well as the model organism com­
munity databases and stock centers (Table 1). The data infrastruc­
ture allows curators to keep indexes synchronized with the source 
databases by using an automated crawling engine and new data 
are released on a weekly basis. All open data from each of these
databases is available to download from the source sites, where 
update frequencies are listed.
The instructions to authors in all cases were consistent, that is, the 
same set of instructions was provided to each author. For antibod­
ies, we only required authors to identify primary antibodies and 
not secondary or tertiary complexes. For tools and databases, we 
focus on freely available tools, generally supported through public 
funding and not commercial tools. Authors were asked to insert the 
correct citation for the resource into the text of the materials and 
methods section and in the keywords. A help desk was established 
by the RII working group that provided help if an author encoun­
tered difficulty. In most cases, requests were handled in less than 
24 hours.
If a resource was not found via the portal, authors were given the 
option of submitting the resource to obtain an identifier. For anti­
bodies and software/databases, which are found in databases main­
tained within the NIF, submission was handled through the Resource 
Identification Portal. For model organisms, the author was referred 
to the authoritative model organism database. All new submissions 
were curated by their respective databases and the data was pulled 
back into the RII portal weekly so that authors could see their newly 
registered antibodies or software tools in about a week.
Figure 1. Resource Identification Initiative portal where authors are asked to find the Research Resource Identifiers (RRIDs) for 
inclusion in the methods section of their publication. The workflow for authors is to select their resource type (see community resources box), 
type in search terms (note, the system attempts to expand known synonyms to improve search results) and open the “Cite This” dialog box. 
The dialog shown here displays the Invitrogen catalog number 80021 antibody with the RRID:AB_86329. The authors are asked to copy and 
paste this text into their methods sections.
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Results
The first RRIDs began appearing in the literature in April of 2014. 
Although the first paper was identified through PubMed, the major­
ity of papers were found via Google Scholar by searching for 
“RRID”. Google Scholar, unlike PubMed, appears to search the full 
text of articles, as it returns snippets of text from the materials and 
methods containing the RRIDs (for example see Figure 2). A search 
in PubMed returns very few papers, indicating that publishers were 
not including the RRIDs outside of the pay-wall. As these papers 
start to appear in PubMed Central where there is full text search, it 
should be possible to find papers for RRIDs through the National 
Library of Medicine. Google Scholar possesses the advantage in 
that it obtains papers without an embargo period and makes them 
available for search, unlike PubMed Central. We therefore present 
statistics and analyses in this paper based upon Google Scholar.
Search via Google Scholar reveals that the RRID prefix is not a 
unique string, but is an acronym for several entities, mostly com­
monly the Renal Risk in Derby clinical study (for example 9). To 
return examples of RRIDs requires the use of additional filters, e.g., 
restricting search to the years 2014 and later. The combination of the 
RRID prefix with the resource accession number is unique however, 
in that searching for a particular RRID, for example RRID:AB_ 
90755 returns only papers that use this research resource (Figure 2).
To address the aims of the pilot project, we tracked the use of 
RRIDs in published papers and journals. We performed an in-depth 
analysis of the first 100 papers found through Google Scholar that
reported RRIDs. For each paper, we examined the methods section 
to determine whether RRIDs were correctly cited - that is that they 
pointed to the correct resource (= true positives), and whether all 
research resources that should have been identified by an RRID 
were appropriately cited (= true negatives). The total number of 
research resources reported in the first 100 papers of the Resource 
Identification Initiative was determined by manual inspection of 
each paper by two independent people. A Google Scholar alert was 
used to track all new papers that contained the term RRID. Each 
paper was downloaded and examined for the snippets of text sur­
rounding research resources (methods or data use sections). Each 
snippet of text surrounding the RRID was copied and pasted into 
a shared document (Supplemental table 1). The RRID was then 
checked against the scicrunch resolving service (for example 
https://scicrunch.org/resolver/RRID:AB_262044) to determine 
what the source database lists about the resource. Information 
was compared in the following way: if the vendor/catalog number 
was present in the snippet and these matched the resolver data, we 
considered that the record was marked accurate. If no informa­
tion about the catalog number was present in the paper, but the 
antibody target or clone number matched then the record was also 
marked accurate, but if the vendor/catalog number information was 
different from the database record or no other information could 
be found about the reagent, then the record was marked inaccu­
rate. The total accuracy is primarily therefore based on the catalog 
number match and importantly does not reflect any upstream prob­
lems with organism or reagent identification inside of the labora­
tories themselves.
A RRIDAB 90755 , B__ Name xUsed
RRID:AB-90755 AjOOQ/e RRID:nif-0000-30467 ImageJ 16
Scholar O RRID:nlx_153890 MATLAB 10
4 results (0.04 sec) RRID:nif-0000-00343 SPM 6
A aeneral principle Governs vision-dependent dendritic oattemina of retinal aanalion cells
RRID:AB_2298772 Anti-NeuN antibody 5
HP Xu, JH Sun. N Tian - Journal of Comparative Neurology, 2014 - Wiley Online Library
... A oolvclonal antibodv aoainst tvrosine hvdroxvlase /TH) (Chemicon. Temecula. CA. AB1542.
RRID:AB_839504 Anti-lba-1 Polyclonal 4
RRID: AB_90755) was used to label TH-positive dopaminergic amacrine cells in the retina. ... and 
western blotting of PC12 cells (single 60-kDa band), RRID: AB_90755, ...
Related articles All 3 versions Cite Save
RRID:AB_90755 Anti-TH antibody 4
RRID:nif-0000-10294 Neurolucida 4
The orexineraic neurons receive svnaotic incut from C1 cells in rats
G Bochorishvili, T Nguyen, MB Coates... - Journal of.... 2014 - Wiley Online Library RRID:nif-0000-23420 SynapseWeb Recns 4
... TH mouse anti-sheen antibodv fAB1542: Millipore: RRID AB 90755) was raised aoainst native
TH from rat pheochromocytoma. As reported by Millipore, this antibody recognizes a protein 
of approximately 60 kDa by western blot of mouse brain lysate. ...
Cite Save
RRID:AB_10013382 GFAP antibody 3
RRID:AB_10049650 AlexaF.488 (A21206) 3
Catecholamineraic connectivity to the inner ear. central auditorv. and vocal motor circuitrv in tl RRID:AB_143165 AlexaF.488 (A11008) 3
Dlainfin midshipman fish corichthvs notatus
PM Foriano. SD Kim. ZM Krzvminska... - Journal of.... 2014 - Wlev Online Library RRID:AB_2079751 ChAT Antibody 3
... The primary antibodies and dilutions were as follows: mouse anti-tyrosine hydroxylase (TH;
1:1,000; Millipore/Chemicon MAB318, RRID: AB_2201528, Temecula, CA), sheep anti-TH RRID:AB_390204 TH Antibody 3
(1:3,000; Millipore/Chemicon AB1542, RRID: AB_90755), and mouse anti-hair cell HCS-1 (1 ...
Related articles All 6 versions Cite Save
GABAeraic and Glutamateraic Efferents of the Mouse Ventral Teamental Area
SR Taylor, S Badurek, RJ DiLeone... - Journal of.... 2014 - Wley Online Library
... Antibody Characterization Sheep anti-tyrosine hydroxylase, polyclonal According to the
RRID:AB_477585 Tubulin Antibody 3
RRID:AB_477627 Vimentin Antibody 3
RRID:nif-0000-00304 FreeSurfer 3
manufacturer fMillioore. Billerica MA: Cat. No. AB1542. RRID: AB 90755). the orimarv antibodv 
was raised against native tyrosine hydroxylase (TH) from rat Page 8 of 70 John Wiley & Sons ...
RRID:nif-0000-10474 R Project 3
Cited by 2 Related articles All 3 versions Cite Save RRID:nif-0000-31484 SAS Project 3
Figure 2. RRIDs found in the published literature. A. Google scholar result for the anti-tyrosine hydroxylase antibody RRID (9/2014; 
http://scholar.google.com/scholar?q=RRID:AB_90755). B. Shows the most used RRIDs in the first 100 papers, by number of papers using the 
identifier. All data is available in Supplementary Table 1 and all identifiers can be accessed in Google Scholar (see also Supplemental Table 1).
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The results of the analysis are summarized in Table 2. The spread­
sheet containing the full analysis is available as a supplementary 
data file. The first 100 papers were published in 15 journals and 
included 630 RRIDs reported by authors. The bulk of the identi­
fiers (572) came from two journals, the Journal of Comparative 
Neurology and the Journal of Neuroscience, as these two journals 
were first to participate both starting the pilot in early February.
Outcome #1: Compliance
As of March 1, 2015 there were 312 papers published with at least 
one RRID, from 44 unique journals (Supplementary files show the 
updated list of journals and a count for each) indicating that hun­
dreds of authors have participated in the pilot project even though 
it is voluntary. Informal feedback from the editors and authors 
via help requests and other correspondence indicates that authors 
who are attempting to find RRIDs are supportive of the aims of the 
project and readily able to find the correct RRIDs.
Authors were willing to add resources to the registries if they 
were not available. Since the project began, over 200,000 anti­
bodies from vendors - both solicited and unsolicited - and at least
200 from individual authors were added to the Antibody Registry 
(http://antibodyregistry.org). In cases where antibodies are sold by 
government-led projects such as NeuroMab from UC Davis, anti­
body identifiers have been included in the antibody manufactur­
er’s web site. Many of the additions were secondary antibodies, 
which were not part of the project but authors felt that they should 
also be identified. In one representative example, Jackson Immu- 
noResearch was contacted by several authors and submitted their 
full catalog to the Antibody Registry, allowing authors to identify 
secondary antibodies. Additionally, there were over 100 software 
tools and databases registered. Many were for common commercial 
statistical tools (e.g., SPSS, GraphPad), technically out of scope 
for the project, but authors did not make the distinction between 
commercial and non-commercial tools. Figure 2 shows the most 
common tools identified by RRID in papers from the first 100 
papers. Commercial tools such as MATLAB, SAS and GraphPad 
were cited along with ImageJ and FreeSurfer. The most common 
antibody was NeuN from Millipore. These same resource identi­
fiers have continued to be very highly cited in subsequent papers, 
with ImageJ cited in 42 papers and the NeuN antibody cited in 8 
papers (Google Scholar March 17, 2015). A comparison of added
Table 2. Summary of journal practices. Journals that added only the instructions to authors are not included in this table (for example BMC). 
The compliance rate was by far the lowest with only instructions to authors; this hovered between 1 and 15% when authors were asked 
by blanket mailing in addition to the instructions to authors (A letter to authors from the editor, when this letter included several pages of 
instructions. Compliance was lowest in Brain Research and Journal of Neuroscience Methods) and very high if the editorial staff asked 
authors directly or suggested identifiers for their manuscript. For two journals this was further facilitated by a special section in the papers 
that described tools, Journal of Comparative Neurology and Neuroinformatics both contain sections that normally describe antibodies and 
software tools, respectively.
Journal Submission Review Acceptance Compliance Notes
Journal of 
Neuroscience
Letter
(1175)
Letter
(163)
Letter (26) ~12% Asking at different stages has no effect on rate of 
compliance
Journal of
Comparative
Neurology
Working 
with Author
Working 
with Author
Working 
with Author
>90% Published an editorial and has a history of proper antibody 
identification back to 2006
Brain and
Behavior
Letter
(~100)
~25% Letters started to be sent out in April 2014, at times the 
editor followed up with authors, did not keep exact records
Neuroinformatics Staff looks 
up data
100% Journal has a section for tools used in the study, which now 
includes RRIDs, several papers incorporated RRIDs prior to 
staff intervention
F1000Research Letter (~50) 12% Approximate figure from editor
Brain Research Letter
(671)
1% Authors receive automatically generated letters with 
multiple instructions, including RII guidelines. Authors are 
asked to incorporate RRIDs or database identifiers (overall 
compliance 1%; for RRIDs <1%).
Journal of
Neuroscience
Methods
Letter
(314)
1% Authors receive automatically generated letters with 
multiple instructions, including RII guidelines. Authors are 
asked to incorporate RRIDs or database identifiers (overall 
compliance 1%; for RRIDs <1%).
Neurobiology of 
Disease
Letter
(291)
3% Authors receive automatically generated letters with 
multiple instructions, including RII guidelines. Authors are 
asked to incorporate RRIDs or database identifiers (overall 
compliance 3%; for RRIDs 2%).
Experimental
Neurology
Letter
(297)
3% Authors receive automatically generated letters with 
multiple instructions, including RII guidelines. Authors are 
asked to incorporate RRIDs or database identifiers (overall 
compliance 3%; for RRIDs <1%).
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resources vs those reported in the first 100 papers indicates that the 
Registries already listed the majority of research resources in each 
of these categories, as the number of new resources added for this 
set represented only 10% of the total reported resources.
Outcome #2: Accuracy
A major concern of the publishers and editors was whether or not 
authors could retrieve RRIDs accurately and whether significant 
editorial oversight would be necessary for quality control (see work­
shop outcome documents at https://www.force11.org/node/4857). 
As shown in Table 3, authors of the first 100 papers were 96% accu­
rate when reporting resource identifiers - that is, they used the cor­
rect identifier as determined by comparing the metadata supplied in 
the article with that in the database, accessible via a resolving serv­
ice (see http://scicrunch.com/resolver/RRID:AB_262044). Authors 
did not create RRIDs for resources they were either unable to find, 
or were not in the databases in 34 clear-cut cases. This constitutes 
a 5.4% false negative rate. In cases where authors tried to identify 
research resources they tended to include identifiers for over 90% 
of them.
A total of 24 errors were found in the 630 RRIDs analyzed. For 
antibodies, 15 antibodies were incorrectly identified (3.8% error 
rate). Inspection of these errors, showed that: three errors were 
copy/paste mistakes where authors mixed up the combination of 
catalog number and identifier for resources actually used in their 
paper; three errors resulted from identifiers missing a digit at the end 
of the ID (for example, “Swant, catalog #6B3, RRID: AB_1000032” 
should have been named RRID: AB_10000320); one error involved 
reporting a reference PMID instead of the resource identifier. The 
apparent cause of the other eight antibody errors was not possible 
to determine. For organisms, seven errors were made (13.2% error 
rate). All of these errors involved mice for which authors used the 
appropriate gene or allele identifier from Mouse Genome Informat­
ics, MGI, rather than the stock number or genotype identifying the 
organism. The allele ID is better than no information, but it is not
Table 3. Summary statistics for the total number of 
research resources reported in the first 100 papers 
of the Resource Identification Initiative. Counts 
were ascertained by two curators going through 
every paper with at least one RRID, and %Error was 
calculated when the information surrounding the 
identifier reported in the paper or the identifier did not 
match the data from the resolving service for each 
entity. For a complete list of resources, including links 
to the resolver, see Supplementary table 1.
Counts %Error
antibody 449 3.56%
organism 53 13.21%
software/database 128 0.78%
total 630 3.81%
percentage
no ID in paper 34 5.40%
pulled new ID 47 7.46%
sufficient for identifying the animal used as the same allele may 
be inserted into different mice of various backgrounds and with 
other alleles, and those mice may have different characteristics. It 
should also be noted that authors using the MGI database (up to 
October 2014), which maintains the authoritative mouse database, 
would be given a set of MGI identifiers for genes and alleles, but 
not genotypes. This shows that authors likely went to MGI to obtain 
their identifiers, but were not able to find the genotype information 
and substituted the allele ID. Currently MGI contains a Google site 
search that now searches the genotype information for all mice sug­
gesting that authors of newer papers can now also find the genotype 
information more easily at MGI. They have also created a tutorial 
for how to obtain a genotype identifier that has been posted on the 
SciCrunch pages. The ideal situation is for MGI, the trusted author­
ity, to point authors to the proper genotype information. The fewest 
errors were made in identifying software tools and databases, with 
only one mistake from 129 total (0.8%). The mistake was made as 
the author apparently used an antibody identifier instead of a tool 
identifier. From the relatively low error rate, it appears that authors 
are able to perform the task accurately, at least for software tools, 
databases, and antibodies.
Outcome #3 Identifiability
An outcome of this study was to determine if the use of RRIDs 
in the literature increased the identifiability of research resources. 
As shown in Figure 3, when authors were asked by their editors to 
provide RRIDs, regardless of their compliance with the RII project, 
the identifiability of research resources significantly increased. We
100%
80%
Pre Pilot
40% ■ Post Pilot
Antibodies Organisms Tools
Figure 3. Resource identification pre- and post-RII pilot study.
Identifiability of the three resource types was determined in journal 
articles that reported RRIDs (post-pilot), and in articles from the same 
journals before the pilot started (from approximately January-March 
2013, pre-pilot). Resources (primary antibodies, organisms, and 
tools) were considered identifiable if they contained an accurate RRID 
or by using the same criteria as described in Vasilevsky et al, 2013 
(PMID: 24032093). For software and databases (which were not 
previously analyzed), these resources were considered identifiable 
if they contained an RRID or reported the manufacturer and version 
number. The total number of resources for each type is: primary 
antibodies pre-pilot, n = 140; primary antibodies post-pilot, n = 433; 
organisms pre-pilot, n = 58; organisms post-pilot, n = 128; tools pre­
pilot, n = 176; tools post-pilot, n = 246. The y-axis is the average for 
each resource type. Variation from this average is shown by the bars: 
error bars indicate upper and lower 95% confidence intervals. Asterisks 
indicate significant difference by a z-score greater than 1.96.
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calculated the percentage of identifiable research resources in the 
same journals, just before the pilot project and after. The reporting 
of research resources pre-pilot was consistent with findings from 
the 2013 study (Vasilevsky et al., 2013), in that roughly 50-60% 
were found to be identifiable. But when asked by their editors, 
researchers used identifying information in 80-90% of research 
resources, showing that they presumably had the data available, but 
did not put it into their papers unless prompted by communication 
from the editors.
Outcome #4 Utility
Consistency of syntax and machine-processability: The ability to 
search all studies that used a particular research resource was a 
prime motivation for this pilot project. The current project had a 
loose definition of “machine-processable” because we did not want 
to impose any requirements on the publishers to modify their jour­
nal submission system for a pilot project. Thus, we opted to craft 
RRIDs as unique, indexable alphanumeric strings that could sup­
port use of web search engines to return papers that used a par­
ticular research resource. We specifically asked authors to place 
the RRIDs only in the materials and methods section, where they 
would normally provide identifying information for a given entity, 
because we wanted to track actual use of the resource and not just 
mentions of it.
For individual RRIDs, the approach was highly successful as is 
illustrated by the ability to type a particular RRID into three search 
engines for the biomedical literature: Google Scholar, PubMed 
and Science Direct and retrieve appropriate papers, e.g., RRID: 
AB_90755 or AB_2298772 (for Google Scholar see Figure 2). It 
is important to note that each of these systems will come back with 
different results because each search tool has different types of data 
about each paper. For example, ScienceDirect has a good full text 
search of all Elsevier content, but it does not search other publish­
ers content. Both PubMed and Scopus search only the abstracts 
and return a subset of articles where authors followed instructions 
to add RRIDs to the keywords, but not those that are only in the 
methods section. Google Scholar is the most comprehensive as 
it appears to search full text and brings back papers that are both 
published and unpublished (usually these are accepted for publica­
tion, but not yet indexed by PubMed). An analysis performed in 
October, 2014 showed varying results from each search engine: 
Google Scholar returned 315 results (from 2014, 174 are true 
RRIDs), and ScienceDirect returned 18 (from 2014, three are 
RRIDs). PubMed revealed 23 papers that contained RRIDs (from 
2014, all identify the resource identification initiative identifiers). 
Scopus returned 48 documents (from 2014, 18 are RRIDs).
The use of a unique string to retrieve RRIDs is aided by a com­
mon syntax. Thus, in our analysis of RRIDs, we also noted whether 
or not the RRID was correctly formed. While authors were 96% 
accurate in supplying identifiers, minor corrections to formatting 
were needed in 34% of RRIDs (66% accuracy). The most com­
mon variant was the addition of extra spaces (RRID:AB_90755 vs 
RRID: AB_90755), other common variants were failure to include 
the RRID prefix (RRID as table header), using various symbols or 
spaces in the identifier, or splitting up the RRID prefix and identi­
fier in a table. These practices make it more difficult to identify the 
RRID through text search alone, and require some additional natural
language processing to identify. We note, however, that the search 
algorithms are improving. Whereas in June, Google Scholar could 
not recognize an RRID that included a space after the colon, e.g., 
RRID:AB_####, by October these types of variants were retrieved. 
Such minor errors could also be avoided by developing authoring 
system upgrades that directly identify RRIDs and insert the proper 
citations into the manuscript.
To promote the development of 3rd party tools around RRID’s, we 
created a resolver service for RRIDs using SciCrunch. Typing http:// 
scicrunch.com/resolver/RRID:AB_90755, will resolve to a landing 
page with meta-data on a particular entity. The resolving service 
allows applications to make use of RRIDs to, for example, enhance 
articles with RRIDs by providing additional information about the 
entity and a link to relevant articles and resources. For instance, 
Elsevier has released their antibody application, which displays 
antibody meta-data in the right hand side panel, next to the article 
(see the screen shot below (Figure 4) for 8: http://www.sciencedi- 
rect.com/science/article/pii/S0306452214008458). The reader can 
browse through antibodies referred to in the article, view complete 
records in antibodyregistry.org and access additional information 
via direct links to GenBank, ZFIN and other relevant databases. The 
application also recommends three most relevant articles published 
in Elsevier journals that refer to the same antibody. The application 
is freely available on ScienceDirect.
Publication practices: Non-open access journals were asked to 
add RRIDs to publication keywords, but our initial findings sug­
gest that this practice was not being consistently followed. Only 
23 papers out of 41 total (as of Oct 20, 2014) were accessible in 
PubMed. Additionally it should be noted that in two cases, iden­
tifiers were removed at typesetting after the initial online version 
of the manuscript was published with the RRIDs. These identifiers 
were removed not only from the manuscript, but also from PubMed 
keywords. Although this was reversed when noted by the working 
group, this demonstrates that successful implementation requires 
knowledge of and agreement by the publishers at all steps.
Discussion
The pilot RRID project has been highly successful in demonstrating 
the utility of a system to aid in identification of these three research 
resources in the literature. We showed that authors were willing to 
adopt new styles of citation for research resources that promoted 
more accurate identification of research resources used in a study, 
and that were more amenable to machine-based identification. To 
date, RRIDs have appeared in over 300 papers from 40 journals. 
With one exception (the Journal of Neuroscience), journals have 
continued their request for RRIDs beyond the initial 3-month pilot 
project and new journals have signed up beyond the initial set that 
started the project. We believe that the success of the project was 
due to the extensive pre-planning that involved the publishers and 
the editors, the limited scope of the initial request, and the rec­
ognized need by researchers for better and more useful reporting 
standards for research resources.
The load on curation staff with participating journals has been mini­
mal and the initial portal prototype appears reasonable for the major­
ity of authors to find their resource identifiers. With >10,000 searches 
in the RII portal, there were approximately 100 help questions.
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Enhanced consumption of salient solutions following 
pedunculopontine tegmental lesions
D A.A. MacLaren1, T. Markovich, D. Daniels”. S.D. Clark” "■ =■ * *
♦ Show more
Highlights
• Rats with lesions of the pedunculopontine tegmentum consume significantly more 20% sucrose than 
controls.
• Excitotoxic, but not selective cholinergic lesions, produced overconsumption.
• Using a contact lickometer system it was found that overconsumption is not due to perseveration.
• Overconsumption only occurs for salient solutions—both sucrose and saline are only overconsumed 
when salient
• An intact PPTg is important for the normal behavioral response to salient stimuli.
Abstract
Rats with lesions of the pedunculopontine tegmental nucleus (PPTg) reliably overconsume high 
concentration sucrose solution. This effect is thought to be indicative of response-perseveration or loss of 
behavioral control in conditions of high excitement. While these theories have anatomical and behavioral 
support, they have never been explicitly tested. Here, we used a contact lickometer to examine the 
microstructure of drinking behavior to gain insight into the behavioral changes during overconsumption. 
Rats received either excitotoxic (ibotenic add) damage to all PPTg neuronal subpopulations or selective 
depletion of the cholinergic neuronal sub-population (diphtheria toxin-urotensin II (Dtx-UII) lesions). We 
offered rats a variety of pleasant, neutral and aversive tastants to assess the general izability and specificity 
of the overconsumption effect. Ibotenic-lesioned rats consumed significantly more 20% sucrose than sham 
controls, and did so through licking significantly more times. However, the behavioral microstructure during 
overconsumption was unaffected by the lesion and showed no indications of response-perseveration 
Furthermore, the overconsumption effect did not generalize to highly consumed saccharin. In contrast.
ELSEVIER
▼ Recommended articles
The mGluRS positive alosteric modulator. CDPP ...
2015, Neurobiology of Disease more
Striatal otigodendrogliogenesK and neuroblast re...
2013. Brain Research more
RANTES has a potential to play a neuroprotective...
2013. Brain Research more
View more articles »
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Figure 4. Representation of the “Antibody data for this article” application developed by Elsevier to enhance articles on ScienceDirect.
The application is available in 206 articles in 19 journals (more information can be found at: http://www.elsevier.com/about/content-innovation/ 
antibodies).
Many of these questions were about scope, i.e., whether a particular 
research resource should be identified. Others were for assistance in 
finding a resource or guidance in adding a resource not yet contained 
in the community authorities. While this is not a large number, it is 
also not insignificant, particularly as the project expands, and cer­
tainly points out the need for specific help functions.
Given the relative completeness of the registries and the rapid 
advance of machine-learning based techniques for entity recog­
nition, we can envision a semi-automated system that assists the 
author in supplying correct IDs. We have already improved our 
ability to detect digital research resources in the literature using 
machine learning (Ozyurt et al., submitted). In this system, machine 
learning is used to identify software tools and databases in text and 
compare the information to Registry listings. The development of 
such functions would allow the development of recommender sys­
tems for authors and automated fact checkers for journal staffs.
Why unique identifiers?
Unique identifiers serve as a primary key or "social security number" 
for identifying a given entity, and providing the ability for search 
engines to parse them is paramount. For search engines, unique 
identifiers are simple methods for disambiguating entities with 
similar names. For identifiers to function in this mode, they need 
to be unique - that is, the same ID should not point to two different 
entities, and they need to be persistent - that is, they need to outlive 
the entity itself. They also need to be at least minimally machine- 
processable. While many authors supplied identifying information 
like the catalog number for an antibody supplied by the vendor, or 
the official strain nomenclature supplied by the IMSR for a mouse, 
neither of these served the required functions. A catalog number is 
not a unique identifier, but rather a useful way for vendors to identify 
their products. If the same antibody is sold by different vendors, it 
will have a different catalog number. If the same antibody is sold in 
different aliquots, it may also have a different catalog number. When
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the antibody is no longer available, the catalog number may disap­
pear, or in some cases be recycled for use with another antibody. 
All of these features are undesirable in an identifier system. The 
Antibody Registry, in contrast, was specifically designed to supply 
useful and stable identifiers for antibodies and not as a commercial 
source of antibodies. Similarly, the strain nomenclature developed 
by the Jackson Laboratory, with its superscripts and special charac­
ters, is useful for human curators to identify a particular strain, but 
causes hiccups in most search engines because of all of the special 
characters. We believe that a well curated registry is essential to 
the success of such a system, because of the necessity of these two 
functions, which currently cannot be replaced with a simple uncu­
rated registration service. For example, we found in the registries 
we maintain (both software and antibodies) that authors sometimes 
register an entity that is found by a curator to be a duplicate.
Which identifiers?
There are many types and formats of identifiers in use today (e.g., 
DOIs, URIs, ARCs), each with varying amounts of associated 
infrastructure and use in different communities. For this project, 
we elected to use simple alphanumeric strings and a common syn­
tax in the form of accession numbers issued by the authoritative 
community-based registries. We relied on each registry to impose 
the uniqueness constraint at the level of the entity, for example 
ensuring that there was only one mouse genotype per unique ID, 
and to ensure standard metadata by curating each entry. The reuse 
of authoritative accessions with the RRID prefix provides maximal 
flexibility and interoperability and minimal ID churn, whilst also 
provisioning for resource identification.
A frequent question regarding the RRID is why we did not use a 
DOI as a unique identifier instead of the Registry Accession number. 
Part of the reason was cultural: researchers were used to supply­
ing accession numbers for Genbank, Gene Expression Omnibus, 
Protein Data Bank, etc. and understand this requirement. Part of 
the reason is practical: unlike DOIs, accession numbers are already 
available for all of the research resources to be identified in this 
pilot and did not require special infrastructure to resolve or cost to 
issue. Part of the reason is also philosophical: DOIs are for digital 
objects, such as individual articles, that live on the web and need to 
be resolvable. A DOI resolves to a particular article, which is self- 
contained - it is the object. In contrast, an antibody does not exist on 
the web but is an independent entity that has data about it scattered 
across various articles. There is no single digital record that is the 
antibody; there are documents and data about the entity. We note 
that in our community we also do not use DOIs to identify people, 
but rather an ORCID, which serves the same purpose as the RRID.
A case could be made for using DOIs to identify particular software 
tools and databases, as they are digital objects. As discussed in the 
next section, our preference is that DOIs be used to identify the 
particular instance used, e.g., the version of data or software and 
any supporting workflows, and that the RRID be used to identify 
the entity or project referenced. Thus, the RRID would be used to 
identify the Protein Databank, and a PDB identifier or a DOI used to 
reference the specific data from the PDB. However, we believe that 
if the RRID system is adopted, appropriate identifier systems should 
be set by each community. The RRID syntax is meant to be simple 
and generic and could, in theory, work with any identifier system.
Why coarse granularity?
RRIDs are meant to identify research resources at a fairly high 
level of granularity. At some of the planning meetings, there was 
a push for more granular information, like lot and batch numbers, 
for antibodies. We recognize that this level of granularity is likely 
an important factor in determining how a given reagent performs10. 
However, in the analysis by Vasilevsky et al. (2013) and in our 
experience in resource identification using text-mining, the big­
gest problem was not that authors were not supplying lot numbers 
but that they were not even supplying catalog numbers. Given that 
the catalog numbers themselves do not serve as stable identifiers, 
because antibodies are bought and sold and redistributed by many 
vendors, we elected to tackle the problem of identifying the root 
antibody first, i.e., a particular clone for a monoclonal antibody 
or a type of polyclonal antibody produced by particular proto­
col. To illustrate the problem, consider the study by Slotta10 that 
provided an analysis of the performance of antibodies to NF-KP 
p65, as a follow up to a similar study by Herkenham4. Both stud­
ies performed specificity tests on a variety of antibodies and, as 
is common, did not produce concordant results on all of them. 
Slotta had been the original producer of an antibody now com­
monly known as MAB3026 (AB_2178887) and provided its prov­
enance: “It was transferred to Boehringer-Mannheim as Clone 
12H11, resold to Roche and finally bought by Chemicon, and it is 
now sold as MAB3026.” They then speculate that a mutation may 
have crept in at some point that altered the specificity of the anti­
body. However, it may simply be that as the antibody was tested 
under additional conditions, problems were revealed that had not 
been apparent during more limited applications. The RRID for this 
antibody binds these different representations together so that all 
references to this antibody can be tracked. However, authors are 
encouraged in the citation format to include details about the par­
ticular instance of this antibody, namely, the vendor from which 
the antibody was purchased and the catalog, batch, and lot num­
bers. However, we did not want to overload the ID system to 
require assignment of these different lot numbers different RRIDs 
and maintain the mappings. We also felt that this would grossly 
decrease compliance.
Similarly, for software and databases, we elected to identify just 
the root entity and not a granular citation of a particular software 
version or database. Our main goal in the case of software tools 
and databases was to track broad patterns of utilization of these 
resources (e.g., how many times NeuroMorpho.org was used, as per 
mandate of the NIF, and not particular versions). More complete 
practices for citing software and data sets are emerging from recent 
efforts like the Joint Declaration of Data Citation principles (https:// 
www.force11.org/datacitation), the W3C HCLS dataset description 
(http://tiny.cc/hcls-datadesc), the software discovery index (http:// 
softwarediscoveryindex.org/), and many others. In these cases, 
groups are exploring more complete reporting standards for the 
individual instances (versions, workflows, virtual machines) that 
can be used to replicate the findings.
What are the next steps?
The RII is an example of a grass-roots type of organization that took 
advantage of existing investments by the NIH to solve a problem 
without extensive new infrastructure. The RII is continuing to run 
and has expanded beyond the initial participants. We believe that
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the growth of the initiative indicates that it fills a need not currently 
met by our existing practices and infrastructure.
Should RRIDs be adopted broadly across all of biomedicine? We 
would argue yes, the RRID syntax should become the standard for 
reporting on usage of research resources. We have shown that the 
requirements for this type of broad adoption are: the availability 
of a comprehensive and authoritative registry for the appropriate 
entities; a centralized portal or services that aggregate these regis­
tries into a single search call, and the willingness of a community 
including journals and publishers to support this style of reporting. 
More sophisticated services can be built to improve and automate 
authoring and editorial oversight, but these are not required. The 
solution is therefore accessible both to large commercial publishers, 
and smaller community- or society-based journals.
If RRIDs were to be broadly adopted tomorrow, what are the out­
standing issues regarding implementation and scalability? The first 
issue is one of scope. The current RII focused on three types of 
research resources which were broadly used and a known source 
of variability within experiments. Should all research resources be 
similarly identified, i.e., every chemical, salt, instrument? We think 
such an approach would be clumsy and difficult to implement. We 
can imagine a future where all reagents and tools are bar coded and 
scanned as they are used in a study. However, as long as humans are 
responsible for supplying identifiers, we think that the effort should 
focus on certain types of known problematic entities for which bet­
ter metadata and ability to query across papers is required. Given 
the recent problems associated with certain cell lines, for example, 
these are obvious candidates6. The advantage of the current system 
is that it allows communities who have taken the steps to aggregate 
and organize resources that are of use to them to agree to include 
the RRID syntax and single entry point.
The second issue is governance. We deliberately designed a decen­
tralized system that gives control of issuing identifiers to multiple 
authorities. Such a model requires some governance, in the form of 
willingness of the authorities to maintain the integrity of any identi­
fiers and links and implementation of a policy regarding entities 
that are no longer available. We would also need some governance 
to ensure that multiple, uncoordinated authorities are not issuing 
IDs for the same research resource and that the IDs assigned to each 
entity are unique. The latter constraint is handled by the centralized 
aggregation service currently provided by SciCrunch, however it 
may be handled by Identifiers.org or other services in the future. 
Further, the RRID project promotes consistent citation of research 
resources at a first level identifiability. We believe that more granu­
lar reporting standards can and should work hand in hand with the 
RRIDs and could be coordinated with the authoritative communi­
ties, for example, versioned software releases in GitHub.
We believe that the RRID project lays an important foundation for 
creating a type of “universal product code” (UPC) to help alert the 
scientific community when issues are raised about key research 
resources. Reagents and tools are not perfect and problems can arise, 
as the resources themselves can have issues as they are tested across 
various paradigms and systems. Even when a resource initially per­
formed well, due to spontaneous mutations in biological resources 
and interactions between particular software tools and platforms,
problems can arise over time. For example, two recent papers have 
published extensive tests showing that common antibodies for 
NF-Kb show non-specificity under some circumstances7,10. Many 
of these antibodies are extensively used in the literature, but readers 
of a particular article have no way of knowing that concerns have 
been raised. We have similar examples with software tools3, data 
sets1,5 and genetically modified animals2. We have an infrastructure 
in place, CrossMark, to alert readers of a particular article that an 
addendum or erratum has been posted. The RRID system can serve 
as the basis for a similar system for research resources.
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The aim of this study was to determine the feasibility and utility of asking authors to include RRIDs when 
submitting a manuscript. The process for making these determinations was well-considered and the 
experience and professional relationships of the authors helped greatly in enabling the study to reach the 
number of journals and submissions that it reached. The analysis of the data was described well and 
carried out well, making it possible to replicate the experiment, in theory. As much of this study did 
depend on professional relationships, it's not clear if it could be replicated in practice, but given the nature 
of the study, this is expected. The authors are to be commended in particular for supplying the raw data 
supporting the analysis in a usable form as supplementary data, This improved my understanding of the 
work.
With regard to the 4 outcome measures (Compliance, Accuracy, Identifiability, and Utility) the scoring 
method is clear and well-described, but I felt like there were some important aspects of the data that were 
not addressed by the authors. With respect to compliance, it could be said that receiving 312 papers with 
572 identifiers shows willingness to contribute, but the data in Table 2 suggest that reaching this level of 
compliance required a very hands-on approach by the editors. This suggests that compliance may be 
actually fairly hard to get. It's encouraging that 200 new antibody entries were created by authors, but it 
would have been good to see more data on the prevalence of other resources.
With regard to the accuracy goal, a user study of a group of authors going through the workflow would 
have a useful addition to the study to help determine where the trouble spots for authors arise. Are they in 
the lookup on the SciCrunch portal or, as suggested for the case of MGI, at the registry itself?
The identifiability pre-pilot results are consistent with the results we reached in our analysis of the 
Reproducibility Project: Cancer Biology set of papers. The authors assert that authors are able to perform 
the task accurately for software tools, but it is worth noting that software tools had low identifiability before 
and improved the least. Some discussion about why that is the case would be useful.
Regarding utility, evidence is presented that RRIDs are highly useful because an RRID can be entered 
into Google Scholar and a link to a paper mentioning that RRID can be retrieved. This is perhaps the 
weakest part of the study, because the utility criteria were that a query could be constructed to show all 
the publications in which the resource were used could be found. They report data that only 174 identifiers 
could be found in Google Scholar, but it's not clear how this data was obtained, not exactly what the 
numbers refer to. The exact query used for each search index should be supplied & the results 
themselves should have been stored. Given the lack of detail around these points, it's hard to judge if it's
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actually possible to conduct these queries in a systematic fashion. The discussion about the failure of 
researchers to include RRIDs in a consistent form shows the current method to get RRIDs inserted in the 
literature is not sufficient for widespread use, and the level of support required by the SciCrunch site 
maintainers (100 queries for 10000 searches) also suggests that this approach would not scale. Given the 
lack of an API for Google Scholar, the approach used is understandable, and it's noted that the RRID 
Resolver page at SciCrunch does link to a PubMed query for papers mentioning the resource, but there is 
a text mining API available for ScienceDirect papers which would have been a better choice for assessing 
presence in ScienceDirect. Overall, the study would have been improved by the addition of a data 
scientist & must be judged to have failed on the utility criteria as established. This doesn't mean RRIDs 
are shown not to be useful; on the contrary, it's clear that RRIDs do allow a researcher to find the actual 
resource used, so in that respect they're quite useful indeed and the resolver page is very helpful. There's 
a case for broader utility to be made, as well, with the example of the "Antibody data for this article" article 
enhancement on ScienceDirect.
It would also have been useful to see a more extended discussion of the sustainability of this project. For 
example, are journals to take this on as a means to add value, and if so, who pays for the maintenance of 
the SciCrunch resolver?
Overall, the authors have presented good quality data on the feasibility and usability of asking authors to 
contribute RRIDs to publications and the publishing community should consider this study when 
considering ways to enrich the literature for text and data mining purposes.
The takeaways for me are:
Just asking authors via the information for authors pages or via one-off emails does not work.
Letting authors enter RRIDs manually detracts from the utility of the identifiers. There's a big opportunity 
for machine learning approaches here to identify and suggest RRIDs at submission.
Non-open access articles inhibit research by preventing the full-text indexing of their articles by search 
indexes.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that 
it is of an acceptable scientific standard.
Competing Interests: I am co-founder of the Reproducibility Initiative, so I'm favorably inclined towards 
anything that looks to improve reproducibility. I also work for Mendeley, a service for researchers which is 
engaged in text and data mining of literature. Mendeley is owned by Elsevier, which developed the 
'Antibody data from this article" widget shown as an example in this paper.
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This manuscript is overall well written with an appropriate title. The abstract provides an adequate 
summary and the design and explanation are sound. I believe the conclusions are justified and the data 
provided is adequate to support them. The subject is valuable to many researchers and provides an 
important service to researchers going forward. I have a few minor grammatical issues to report:
1. The sentence "The pilot project has focused on a limited number of resources - antibodies, 
software tools/databases, and model organisms" should be "The pilot project focused on a limited 
number of resources..."
2. in "accession number, as Genbank does for gene" should use "GenBank"
3. For sentence "Over the minimum 3-month window, each partner journal would request that authors 
supply RRIDs in a standard format as a citation to indicate the use of any of these three types of 
research resources."
In this context, what the "three types of research resources" are is unclear.
4. The sentence "As these papers start to appear in PubMed Central where there is full text search, it 
should be possible to find papers for RRIDs through the National Library of Medicine." is a little 
confusing, maybe "As these papers start to appear in PubMed Central, where full text search is 
possible, papers utilizing RRIDs will be identifiable through the National Library of Medicine." is 
better? Yes, being overly nit picky, but I had to read it twice to get it.
5. Verb tense should be reviewed throughout the manuscript to ensure consistency.
6. Uses of dashes such as "...from vendors - both solicited and unsolicited - and at.." occurs 
throughout the manuscript. This seems nonstandard?
7. In Figure 3, I could not see the pre-pilot bar. This could be due to something with my browser, but 
worth checking out.
8. In the Discussion, the sentence "The pilot RRID project has been highly successful in 
demonstrating the utility of a system to aid in identification of these three research resources in the 
literature" should reiterate what three research resources it is referring to.
9. Review the number of uses of the word "however" and how close to each other they occur. For 
example, "However, authors are encouraged in the citation format to include details about the 
particular instance of this antibody, namely, the vendor from which the antibody was purchased 
and the catalog, batch, and lot numbers. However, we..."
And lastly, the link referred to here "A list of the participating journals is available on the Force11 website ( 
https://www.force11.org/RII/SignUp)." did not provide a list of the multiple immunology journals in the 
Elsevier family that are participating. The page just shows the Elsevier logo.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that 
it is of an acceptable scientific standard.
Competing Interests: No competing interests were disclosed.
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